Pediatric meningioma with a Novel MAML2-YAP1 fusion variant: a case report and literature review

BMC Pediatr. 2022 Dec 3;22(1):694. doi: 10.1186/s12887-022-03747-8.

Abstract

Background: Pediatric meningioma with YAP1 fusion is a rare subset of meningiomas. Currently, there are lack of integrated clinical, radiological, and pathological features on this subset. Here, we reported a case of pediatric meningioma with a novel MAML2-YAP1 fusion variant and reviewed the relevant literature.

Case presentation: We presented a case of 12-year-old boy with meningioma adjacent to the superior sagittal sinus and falx. Simpson grade II gross total resection was performed after diagnosis. Pathologically, he was diagnosed as WHO grade I meningothelial meningioma with rhabdoid features. A next-generation sequencing-based gene panel was performed to determine the molecular features for potential treatment, and a novel MAML2-YAP1 fusion break point was identified.

Conclusion: Pediatric meningioma with the fusion of YAP1 and MAML2 genes is more likely to have pathological features of rhabdiod cells, which needs to be validated in large-scale studies for exploring better treatment under the integrated diagnosis.

Keywords: Gene fusion; MAML2; Next-generation sequencing; Pediatric meningioma; YAP1.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Child
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Male
  • Meningeal Neoplasms* / diagnostic imaging
  • Meningeal Neoplasms* / genetics
  • Meningioma* / diagnostic imaging
  • Meningioma* / genetics
  • Trans-Activators / genetics
  • Transcription Factors / genetics

Substances

  • Transcription Factors
  • MAML2 protein, human
  • Trans-Activators